A Safety Study of SGN-CD33A in AML Patients

Clinical trial NCT01902329 · COMPLETED

Trial details

NCT number: NCT01902329
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Myeloid Leukemia Acute Promyelocytic Leukemia

Start date: 2013-07-01
Primary completion: 2016-03-18
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.